Momeson

Recommended Dosages in Patients 4 Years of Age and Older. Previous Therapy : Patients ≥ 12 years who received bronchodilators alone Recommended Starting Dose: 220 µg once daily in the evening Highest Recommended Daily: 220 µg twice daily or as 440 µg once daily Previous Therapy : Patients ≥ 12 years who received inhaled corticosteroids Recommended Starting Dose: 220 µg once daily Highest Recommended Daily: 440 µg once daily or 440 µg twice daily. Previous Therapy : Patients ≥ 12 years who received oral corticosteroids Recommended Starting Dose: 4400 µg once daily Highest Recommended Daily: 440 µg once daily or 440 µg twice daily.

Mometasone is a corticosteroid demonstrating anti-inflammatory properties. The precise mechanism of corticosteroids action on allergic rhinitis is not known. Corticosteroids have been shown to have a wide range of effects on multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, and cytokines) involved in inflammation.

Generally side effects are mild like headache, viral infection, sore throat, nosebleeds and coughing. Systemic and local corticosteroid use may result few side effects like candida infection, immunosuppression, hypercorticism, adrenal suppression, growth effects, glaucoma and cataracts.

Hypersensitivity to any of the ingredients of this preparation contraindicates its use. Mometasone Furoate therapy is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required.

Use with caution in active or inactive tuberculosis infection, herpes simplex virus infection of the eye, untreated infections affecting the body as a whole etc.

Ketoconazole, a strong inhibitor of cytochrome P4503A4 may increase plasma levels of Mometasone Furoate during concomitant dosing.